title: Osteopontin can act as an effector for a germline mutation of BRCA1 in malignant transformation of breast cancer-related cells.
abstract: Breast cancer-associated 1 (BRCA1) plays an important role in breast cancer initiation and progression through its functions in the cell cycle and DNA repair processes; however, its role in metastatic development in human breast cancer is still poorly understood. We have previously shown that osteopontin (OPN) expression was suppressed by wild-type BRCA1 (Wt.BRCA1) and that a natural mutant allele of BRCA1 (Mut.BRCA1) diminished the effect of Wt.BRCA1 on OPN in vitro. In this study, we show that while Wt.BRCA1 suppresses OPN-induced metastasis in a rat syngeneic system, Mut.BRCA1 enhances the development of metastasis through OPN, suggesting that OPN and BRCA1 work closely to regulate metastatic development in the rat. To test whether these findings are relevant to human breast cancer, we have investigated the relationship between BRCA1, OPN, and metastatic properties in human breast cancer-related cells. Using western blot analysis, we show that Wt.BRCA1 suppresses, while Mut.BRCA1 enhances, OPN protein expression; and in parallel that Wt.BRCA1 suppresses, while Mut.BRCA1 enhances, OPN-mediated in vitro properties associated with the metastatic state in both MCF-7 and MDA MB435s cells. Overall, these results suggest that Mut.BRCA1 can elicit some of the changes involved in metastatic progression in human breast cancer via the overexpression of OPN.
authors.affiliation: Centre of Cancer Research and Cell Biology, Queen's University Belfast, Belfast, Ireland. m.el-tanani@qub.ac.uk
authors.forename: Mohamed K
authors.initials: MK
authors.lastname: El-Tanani
authors.forename: Hiu-Fung
authors.initials: HF
authors.lastname: Yuen
authors.forename: Zhanzhong
authors.initials: Z
authors.lastname: Shi
authors.forename: Angela
authors.initials: A
authors.lastname: Platt-Higgins
authors.forename: Niamh E
authors.initials: NE
authors.lastname: Buckley
authors.forename: Paul B
authors.initials: PB
authors.lastname: Mullan
authors.forename: Denis Paul
authors.initials: DP
authors.lastname: Harkin
authors.forename: Patrick G
authors.initials: PG
authors.lastname: Johnston
authors.forename: Philip S
authors.initials: PS
authors.lastname: Rudland
mesh_terms: D000818:Animals; D001943:Breast Neoplasms / Q000235:genetics / Q000473:pathology*; D002448:Cell Adhesion; D045744:Cell Line, Tumor; D049109:Cell Proliferation; D002471:Cell Transformation, Neoplastic; D005260:Female; D019398:Genes, BRCA1; D018095:Germ-Line Mutation; D006801:Humans; D009361:Neoplasm Invasiveness; D053495:Osteopontin / Q000235:genetics / Q000502:physiology*; D051381:Rats; D017208:Rats, Wistar; D014162:Transfection
chemical_list: D053495:Osteopontin
references.citation: J Biol Chem. 2001 Nov 9;276(45):41675-82
references.pmid: 11522780
references.citation: J Natl Cancer Inst. 1983 Dec;71(6):1227-40
references.pmid: 6418941
references.citation: Clin Exp Metastasis. 1998 Feb;16(2):129-39
references.pmid: 9514094
references.citation: Cancer Res. 2002 Jun 15;62(12):3417-27
references.pmid: 12067984
references.citation: Surgery. 2008 Jun;143(6):803-12
references.pmid: 18549897
references.citation: Front Biosci. 2008 May 01;13:4276-84
references.pmid: 18508510
references.citation: Exp Cell Res. 2009 Jan 15;315(2):304-12
references.pmid: 19026636
references.citation: Mol Cell. 1999 Oct;4(4):511-8
references.pmid: 10549283
references.citation: Invasion Metastasis. 1991;11(4):204-15
references.pmid: 1765433
references.citation: Breast Cancer Res Treat. 2007 Jul;104(1):13-9
references.pmid: 17004106
references.citation: Oncogene. 2008 Dec 4;27(57):7139-49
references.pmid: 18794800
references.citation: J Biol Chem. 2006 Sep 8;281(36):26587-601
references.pmid: 16807234
references.citation: J Natl Cancer Inst. 1999 Jun 2;91(11):943-9
references.pmid: 10359546
references.citation: Oncogene. 1996 Jul 4;13(1):97-104
references.pmid: 8700559
references.citation: Science. 2003 Oct 24;302(5645):591-3
references.pmid: 14576418
references.citation: Am J Pathol. 2006 Jul;169(1):233-46
references.pmid: 16816376
references.citation: Clin Cancer Res. 1997 Apr;3(4):605-11
references.pmid: 9815727
references.citation: Oncogene. 1999 Jul 22;18(29):4237-46
references.pmid: 10435636
references.citation: Clin Cancer Res. 2006 Jun 1;12(11 Pt 1):3337-43
references.pmid: 16740755
references.citation: Proc Natl Acad Sci U S A. 2000 May 9;97(10):5208-13
references.pmid: 10792030
references.citation: Clin Exp Metastasis. 2004;21(6):543-52
references.pmid: 15679052
references.citation: J Biol Chem. 2004 May 14;279(20):20794-806
references.pmid: 14990565
references.citation: FASEB J. 1993 Dec;7(15):1475-82
references.pmid: 8262332
references.citation: J Biol Chem. 1999 Jun 25;274(26):18808-12
references.pmid: 10373498
references.citation: Lancet. 1996 May 25;347(9013):1493
references.pmid: 8676668
references.citation: Science. 1994 Oct 7;266(5182):66-71
references.pmid: 7545954
references.citation: Pathobiology. 1990;58(6):329-42
references.pmid: 2078312
references.citation: Cancer Res. 1994 May 15;54(10):2785-93
references.pmid: 8168111
references.citation: Oncogene. 2006 Apr 6;25(15):2192-202
references.pmid: 16288209